1-8 of 8
Larry Witte
Close
Sort by
Journal Articles

The Anti-FLT3 Monoclonal Antibody EB10 Is Cytotoxic to FLT3 Inhibitor Resistant Cells In Vivo.

Obdulio Piloto, BS, Melissa Griesemer, BS, Bao Nguyen, MS, Li Li, PhD, Yiwen Li, PhD, Larry Witte, PhD, Daniel J. Hicklin, PhD, Donald Small, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 1511.
https://doi.org/10.1182/blood.V106.11.1511.1511
Published: 2005
Journal Articles

FLT3 Immunotherapy Can Eliminate Engraftment of ALL Cells in NOD/SCID Mice.

Obdulio Piloto, BS, Bao Nguyen, MS, Patrick Brown, MD, Kyu-Tae Kim, PhD, David Huso, PhD, Yiwen Li, PhD, Larry Witte, PhD, Daniel J. Hicklin, PhD, Donald Small, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 869.
https://doi.org/10.1182/blood.V106.11.869.869
Published: 2005
Journal Articles

EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces NOD/SCID Engraftment of AML Cell Lines and Primary Blasts.

Obdulio Piloto, B.S., Mark Levis, M.D./Ph.D., Li Li, Ph.D., Bao Nguyen, M.S., Kyu-Tae Kim, Ph.D., David Huso, Ph.D., Yiwen Li, Ph.D., Hongli Li, Ph.D., Mei-Nai Wang, Ph.D., Larry Witte, Ph.D., Daniel J. Hicklin, Ph.D., Donald Small, M.D./Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2534.
https://doi.org/10.1182/blood.V104.11.2534.2534
Published: 2004
Journal Articles

EB10, an Anti-FLT3 Monoclonal Antibody, Selectively Targets ALL Cell Lines and Primary ALL Blasts without Interfering with Normal Hematopoiesis.

Obdulio Piloto, B.S., Patrick Brown, M.D., Li Li, Ph.D., Bao Nguyen, M.S., Kyu-Tae Kim, Ph.D., David Huso, Ph.D., Yiwen Li, Ph.D., Hongli Li, Ph.D., Mei-Nai Wang, Ph.D., Larry Witte, Ph.D., Daniel J. Hicklin, Ph.D., Donald Small, M.D./Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2744.
https://doi.org/10.1182/blood.V104.11.2744.2744
Published: 2004
Journal Articles

Supression of FLT3-Expressing Leukemia by a Monoclonal Antibody-Auristatin Conjugate.

Yiwen Li, MD, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Dale Ludwig, PhD, Larry Witte, PhD, Zhenping Zhu, MD, PhD, Peter Bohlen, PhD, Damon Meyer, PhD, Angelyn Larkin, Peter Senter, PhD, Daniel Hicklin, PhD
Journal: Blood
Blood (2004) 104 (11): 1788.
https://doi.org/10.1182/blood.V104.11.1788.1788
Published: 2004
Journal Articles

Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody

Yiwen Li, Hongli Li, Mei-Nai Wang, Dan Lu, Rajiv Bassi, Yan Wu, Haifan Zhang, Paul Balderes, Dale L. Ludwig, Bronislaw Pytowski, Paul Kussie, Obdulio Piloto, Donald Small, Peter Bohlen, Larry Witte, Zhenping Zhu, Daniel J. Hicklin
Journal: Blood
Blood (2004) 104 (4): 1137–1144.
https://doi.org/10.1182/blood-2003-07-2585
Published: 2004
Includes: Supplemental data
Journal Articles

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

Rui Zheng, Mark Levis, Obdulio Piloto, Patrick Brown, Brenda R. Baldwin, Norbert C. Gorin, Miloslav Beran, Zhenping Zhu, Dale Ludwig, Dan Hicklin, Larry Witte, Yiwen Li, Donald Small
Journal: Blood
Blood (2004) 103 (1): 267–274.
https://doi.org/10.1182/blood-2003-06-1969
Published: 2004
Journal Articles

Expression of VEGFR-2 and AC133 by circulating human CD34 + cells identifies a population of functional endothelial precursors

Mario Peichev, Afzal J. Naiyer, Daniel Pereira, Zhenping Zhu, William J. Lane, Mathew Williams, Mehmet C. Oz, Daniel J. Hicklin, Larry Witte, Malcolm A. S. Moore, Shahin Rafii
Journal: Blood
Blood (2000) 95 (3): 952–958.
https://doi.org/10.1182/blood.V95.3.952.003k27_952_958
Published: 2000